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Abstract
Gap junction channels are assembled from connexins (Cx) and allow for intercellular 
communication. In our study, we characterized the role of Cx26 and Cx43 in three isogenic 
melanoma cell lines (FO, F10 and BL6) that vary in aggressiveness in mice. However, all 
three melanoma cell lines were shown to have similar levels of cell proliferation and 
anchorage-independent growth in soft agar, while the BL6 cells migrated significantly slower 
than FO and F10 cells. Cx26-based gap junctions were present in a subpopulation of all cell 
lines, while, Cx43 was localized to an intracellular compartment and only able to assemble 
into gap junction channels when E-cadherin was ectopically expressed. RNAi-based 
knockdown of Cx26 in BL6 cells showed a reduction in melanin levels and enhanced cell 
migration. Interestingly, BL6 cells with reduced Cx26 levels formed fewer microtumors in 
the 3D organotypic epidermis. All microtumors formed in the organotypic epidermis had a 
loss in Cx26 and Cx43 expression and remained isolated from the gap junction competent 
kératinocytes. Our results suggest that melanomas decrease connexins expression and are gap 
junction communication incompetent with each other and the surrounding kératinocytes. 
Thus, we proposed that the gap junction isolation in melanoma cells may allow for tumors to 
progress into more advance disease.
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1.1 Gap junctional intercellular communication
Vertebrates contain a collection of vital organs, each with a different purpose in 
regulating the body. These organs can be further compartmentalized into individual cells 
that rely on cell-cell communication to establish functional integrity with neighboring 
cells and their microenvironments (Goldberg et al 2004). One such communication 
method is through gap junctional intercellular communication (GJIC) between adjoining 
cells (Alexander and Goldberg 2003, Goodenough et al 1996). This enables molecules of 
less than 1 kiloDalton (kDa), such as secondary messengers, ions and metabolites to 
travel between contacting cells. GJIC occurs when several to hundreds of gap junction 
channels cluster together to form plaque-like structures at the site of cell apposition 
(Laird 2006). Gap junction channels are regulated by stimuli that open and close the 
channel, thus altering cell permeability to molecules (e.g. cAMP and calcium) that can 
pass through the pores (Alexander and Goldberg 2003, Goldberg et al 2004). Such 
stimuli include changes in calcium concentration, pH and voltage potential (Goldberg et 
al 2004). Each gap junction channel is composed of two hexamers called hemichannels. 
Hemichannels are assembled from six proteins called connexins (Cx) and have molecular 
weights in humans ranging from 26 kDa to 62 kDa (Sohl and Willecke 2004). These cell 
surface hemichannels are able to pair with hemichannels from an adjoining cell to form 
the complete gap junction channel (Goodenough et al 1996).
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1.2 Connexins
To date, 21 connexin family members have been identified in humans and 20 
connexins in mice (Laird 2006, Sohl and Willecke 2004). Gap junctions composed of 
hemichannels with homogenous populations of connexins are termed homomeric. 
Interestingly, gap junctions can also be formed from hemichannels with a mixed 
population of connexins termed heteromeric arrangements, which include Cx26/Cx32- 
based hemichannels in hepatocytes and Cx46/Cx50-based hemichannels in the lens (Jiang 
and Goodenough 1996, Sosinsky 1995, Vaney and Weiler 2000). The intermixing of 
these connexin family members within the gap junction channel dictates channel pore 
size and selectivity (Cottrell and Burt 2005, Goodenough et al 1996). However, not all 
connexins are compatible and do not form hemichannels, including Cx26 and Cx43. 
While both Cx26-based and Cx43-based hemichannels can traffic to the cell membrane in 
the same cell, there is no evidence to support the interaction of Cx26 with Cx43 in 
forming a heteromeric hemichannel (Gemel et al 2004). To further complicate matters, 
gap junctions can not only assemble from identical hemichannels to form homotypic 
channels but can also assemble from mixed population of hemichannels to form 
heterotypic channels (Cottrell and Burt 2005, Jiang and Goodenough 1996). Connexins 
share similar structural topology, as illustrated by the schematic models of Cx26 and 
Cx43 (Figure 1.1A, B). Connexins have four hydrophobic transmembrane domains, one 
intracellular loop, two extracellular loops, and both the amino and carboxyl termini 
exposed to the cytosol (Goodenough et al 1988, Goodenough et al 1996, Sohl et al 2004). 
The conserved regions amongst the connexin family members reside in the four 
transmembrane domains, the extracellular loops and the amino terminal.
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Figure 1.1 Cx43 and Cx26 share similar topology and both form gap junctions in 
kératinocytes
Connexins have four transmembrane domains, two extracellular loops, one 
intracellular loop and both the amino and carboxyl termini are exposed to the 
cytoplasm. Cx26 and Cx43 are two connexin isoforms that differ in the length of 
the intracellular loop and the carboxyl terminal (A, B). In kératinocytes, both 
Cx43 (red) and Cx26 (red) are able to successfully form gap junction plaques at 
the plasma membrane as indicated by the arrows (C, D). Nuclei were stained blue 





Kera tinocytes Kera tinocytes
Furthermore, the extracellular loops each have three highly conserved cysteine residues 
that are connected by intramolecular disulphide bonds (Harris 2001, John and Revel 
1991, Sohl and Willecke 2004, Zhang and Nicholson 1994). The carboxyl terminal, 
however, is highly variable in length and can undergo phosphorylation, resulting in 
changes in channel selectivity (Cottrell and Burt 2005, Musil and Goodenough 1991). 
Interestingly, connexins are also highly conserved between species such as rodents and 
humans, suggesting that mechanistic findings in rodents may also be applicable to 
humans (Cruciani and Mikalsen 2006, Goodenough et al 1996, Sohl and Willecke 2004).
1.3 Gap junction-independent mechanisms
Connexins not only enable intercellular communication between cells, but also 
have GJIC-independent mechanisms such as hemichannels, cross-talk with tight junctions 
and interaction with binding proteins at the carboxyl-tail (Laird 2006). Hemichannels 
allows small molecules to pass between the extracellular and intracellular environments 
(Goodenough and Paul 2003).For example Cx43-based hemichannel activity is important 
in astrocytes (Froger et al 2010) that may be related to ATP release (Kang et al 2008). 
Connexins also indirectly interact with tight junction complexes at the cell surface 
affecting cellular functions like motility and morphology (Dbouk et al 2009, Giepmans 
2004, Kojima et al 2002). Several structural junctional and cytoskeletal proteins also 
interact with connexins; these include ,zona occludens-1, alpha- and beta- tubulin 
(Giepmans et al 2001, Laird 2006) and claudins (Giepmans 2004). However, due to the 
variability of the carboxyl-tail length among the connexin family members different 
connexins have different binding partners. Cx43 in comparison to Cx26 has a much 
longer carboxyl- tail that can interact with a greater number of binding proteins
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(Giepmans 2004). The carboxyl-tail of Cx43 can transiently interact with tyrosine 
kinases, serine/threonine targeted protein kinases and phosphatases. Cx26 however 
cannot be phosphorylated. Presently few binding proteins have been identified for Cx26 
other than organ of corti protein 1 and caveolin (Henzl et al 2004, Schubert et al. 2002) 
while Cx43 has numerous binding partners (Laird 2010). Not only can connexins interact 
with binding proteins to cause a downstream effect, the interaction is in fact bi­
directional, allowing binding proteins to also regulate connexin function (Laird 2006).
1.4 Connexin life cycle
Connexins have a half-life of only a few hours suggesting that gap junctions are 
rapidly being formed and removed between contacting cells (Beardslee et al 1998, Laird 
et al 1991, Laird 1996). This fast turnover rate is mediated by the continuous production, 
trafficking, channel assembly and degradation of connexins, enabling cells to rapidly 
adjust to physiological changes (Fallon and Goodenough 1981, Laird 2006). Since Cx43 
is the most abundant of all connexin family members and also the most studied, its life 
cycle is the best characterized (Cottrell and Burt 2005, Laird 2006, Musil and 
Goodenough 1991). The majority of connexins, including Cx43, undergo co-translational 
insertion into the endoplasmic reticulum (ER), which is followed by trafficking through 
the Golgi apparatus to the plasma membrane (Laird 2006, Musil and Goodenough 1993). 
Some connexins are able to oligomerize in the ER into hemichannels, while other 
connexins like Cx43 form hemichannels within the trans- Golgi apparatus before 
trafficking to the plasma membrane (Laird et al 1995, Maza et al 2005). In previous 
studies, Cx26 has been reported to be both co-translationally and post-translationally 
inserted into the ER and even be directly inserted into the plasma membrane (Ahmad and
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Evans 2002, Zhang et al 1996). However, these reports have been challenged as a more 
recent study demonstrated that Cx26 follows a classical secretory pathway, passing 
through the Golgi apparatus before reaching the plasma membrane (Thomas et al 2005). 
Collectively, these findings suggest that connexins, including Cx26 and Cx43 expressed 
in kératinocytes, likely share similar secretory pathways, resulting in their plasma 
membrane localization (Figure 1.1C, D).
At the plasma membrane, hemichannels can freely diffuse until they dock with 
compatible hemichannels from an adjoining cell. For Cx43-based gap junction channels, 
cadherins have been shown to facilitate the assembly of gap junction channels at the 
plasma membrane (Laird 2006). InNIH3T3 fibroblast cells, the co-assembly ofN- 
cadherin with Cx43 is required for gap junction formation (Wei et al 2005). Conversely, 
in rat liver epithelial cells, the expression of E-cadherin in cells with low levels of N- 
cadherin was able to promote the assembly of Cx43-based gap junction channels 
(Govindarajan et al 2010). This suggests that use of cadherins in the assembly of Cx43- 
based gap junctions may be a cell-type specific process. Gap junction plaques are then 
internalized as a whole or as fragments to form annular junctions, also known as 
connexosomes (Jordan et al 2001, Laird 2006). Connexosomes are double-membrane 
structures containing the gap junction constituents from two adjacent cells. Once 
internalized, connexins can either be targeted to the lysosomes or proteasomes for 
degradation (Beardslee et al 1998, Leithe and Rivedal 2004).
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1.5 Melanocytes
Melanocytes are the second most common cell type found in the stratum basale 
within the epidermis (Figure 1.2). Melanocytes provide protection by producing and 
releasing the pigment melanin, which prevents ultraviolet rays from damaging DNA in 
skin cells (Park et al 2009). Ultraviolet B radiation (UVB 280-320nm) accounts for the 
majority of DNA damage that occurs within the skin (Gilchrest and Eller 1999, Park et al 
2009). Fortunately, melanin pigments are able to absorb 50-75% of the energy to 
minimize damage by converting it into heat and reduce damages caused by reactive 
oxygen species (Park et al 2009). Melanin is produced and stored inside melanocyte 
organelles called melanosomes (Park et al 2009, Yamaguchi and Hearing 2009). 
Melanocytes are able to distribute the melanin to kératinocytes via dendrites. 
Kératinocytes ingest melanin, which proceeds to form a ‘cap’ like structure above the 
nucleus to prevent DNA damage. Melanin production can also be influenced by UV- 
induced damage to kératinocytes, which can signal more melanin production in 
melanocytes (Kvam and Dahle 2003, Yamaguchi et al 2008). Interestingly, there are two 
types of melanin pigment: pheomelanin and eumelanin. Eumelanin is responsible for 
producing the black-brown pigment while pheomelanin produces a red-brown color (de 
Zwaan and Haass 2010). It has been suggested that the intermediate state of the 
pheomelanin molecule, during UV absorption, is harmful to cells by enhancing DNA 
damage through the generation of reactive oxygen species. Hence, individuals with pale 
skin, red hair, and freckles are more prone to developing melanoma skin cancers that are 
derived from melanocytes and non-melanoma skin cancers derived from kératinocytes 
(de Zwaan and Haass 2010, Park et al 2009).
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Figure 1.2 Schematic diagram of melanoma microtumor within the epidermis.
The epidermal layers are derived from kératinocytes located in the stratum basale. 
As kératinocytes differentiate, they form the stratum spinosum, stratum 
granulosum and stratum comeum. When melanocytes found in the stratum basale 
undergo sufficient DNA damage, they transform into melanomas. As melanoma 
microtumors become more aggressive, they are able to invade through the stratum 










1.6 Kératinocytes in the epidermis
Kératinocytes are the most abundant cell type in the epidermis and are responsible 
for replenishing the entire epidermal layer. The epidermis acts as a protective barrier 
from thermal stress, dehydration, and many other environmental irritants (Cartlidge 
2000). Kératinocytes differentiate into multiple epidermal layers that can be sub-divided 
into many strata (Figure 1.2). The stratum basale, otherwise known as the basal layer, 
forms a barrier separating the epidermis and the dermis (Cartlidge 2000). A few non­
proliferating melanocytes are also found in the basal layer (Robinson and Fisher 2009). 
The stratum basale is a single cell layer thick and responsible for maintaining epidermal 
thickness by housing kératinocytes capable of differentiation into other strata of the 
epidermis (Kretz et al 2003, Merrill et al 2001). During differentiation, the basal 
kératinocytes are able to form the stratum spinosum that have many desmosomal 
connections (Haftek et al 2011). Kératinocytes also differentiate into the stratum 
granulosum, which acts as a hydrophobic barrier in the epidermis and undergoes 
apoptosis to form the stratum comeum which helps to prevent dehydration (Cartlidge 
2000, Fuchs and Raghavan 2002, Haftek et al 2011).
1.7 Cancers derived from the epidermis
Exposure of epidermis to UVB can lead to a decreased immune-response, 
increased reactive oxygen species production, and induced DNA damage leading to 
increased production of growth factors (Miller and Mihm 2006). The two major 
classifications of skin cancer are non-melanoma skin cancer (NMSC) and melanoma skin 
cancer (Armstrong and Kricker 1994). NMSC consists of basal cell carcinomas (BCC)
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and squamous cell carcinomas (SCC), both of which are derived from keratinocytes (de 
Zwaan and Haass 2010, O'Bryan and Ratner 2011). BCC as the name implies are 
transformed keratinocytes in the basal layer and accounts for more than 80% of all 
diagnosed skin cancers (Jemal et al 2010). BCC are usually found on the head and neck 
(most UVB exposed areas) and are considered slow growing tumors with a low chance of 
spreading (Netscher et al 2011). SCC are the second most frequently diagnosed skin 
cancers and originate from the differentiated keratinocytes in the suprabasal layers. SCC 
are considered more aggressive than BCC and are likely to invade through the dermis 
(Netscher et al 2011). The most aggressive skin cancers are melanomas (Figure 1.2). 
Patients with these transformed melanocytes have a high mortality rate due to the rapid 
transition of these tumors from benign to metastatic (Jemal et al 2010, Lugassy and 
Barnhill 2007, Miller and Mihm 2006).
1.8 Transformation of melanocytes
When extensive UV-induced DNA damage has occurred melanocytes become 
unable to self-repair and are no longer responsive to regulatory signals from neighboring 
keratinocytes (Kvam and Dahle 2003, Park et al 2009, Yamaguchi et al 2008). This UV- 
induced DNA damage can cause melanocytes to transform into a benign nevus (Braeuer 
et al 2011). The benign nevus (common mole) has increased pigmentation and a loss of 
proliferative control resulting in lesions being formed at the basal layer (Clark et al 
1984). The benign nevus will not progress to cancer unless additional DNA damage 
occurs, such as the activation of specific oncogenes (Braig and Schmitt 2006). For 
example, in the early stages of melanocyte transformation, 15% of melanomas are 
associated with abnormal increases in N-RAS expression (Brunet et al 1999). Likewise,
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50% of melanomas is associated BRAF expression which has been shown to cause 
increased activation of mitogen-activated protein kinase (MAPK) signaling, leading to a 
promotion of melanoma growth (Davies et al 2002).
Additional growth factor signaling can lead to the next stage in melanocyte 
transformation called dysplastic nevi. At this stage, the lesions begin to show 
discoloration, increased horizontal size and form an uneven border along the mole (Clark 
et al 1984, Miller and Mihm 2006). Mutations in the genes that encode tumor- 
suppressors, such as PTEN (Bharati et al 1983, Wu et al 2003) and CDKN2A, which 
regulate cell cycling (Kamb et al 1994, Miller and Mihm 2006), can also increase the 
susceptibility of melanocytes to develop into melanomas. Subsequent to the development 
of the dysplastic nevi, the lesion enters a radial-growth phase and begins to proliferate 
vertically in the epidermis (Clark 1991). Furthermore, the lesions begin to weaken the 
basement membrane with very few tumor branches penetrating through and entering the 
uppermost layer of the dermis. However, melanomas in vivo that have reached this stage 
of transformation are not typically able to form colonies in in vitro soft agar assays 
(MacKie 2002, Miller and Mihm 2006).
The transition from the radial-growth phase to the vertical-growth phase occurs in 
a relatively short period of time. Melanomas at this stage have broken through the 
basement membrane and can penetrate deep into the dermis (Miller and Mihm 2006). 
During the vertical-growth phase, the cells are able to form colonies in the dermis, extend 
into the fat layers and are fully capable of colony formation in soft agar when isolated 
and studied in vitro (Fujita et al 1999, Miller and Mihm 2006). Changes in adhesion 
molecule expression also parallel melanocyte transformation and disease progression.
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Studies have shown E-cadherin to be expressed by both melanocytes and kératinocytes 
and it has been suggested that E-cadherin allows kératinocytes to adhere and regulate 
melanocytes (Haass et al 2004, Hsu et al 2000). During the vertical-growth phase in 
tumor progression, E-cadherin is suppressed, allowing melanomas to proliferate and 
invade through the dermis. At the same time, melanomas have increased N-cadherin 
expression, which permits melanomas to associate with other N-cadherin expressing 
cells, like those found on the vascular endothelium thereby facilitating tumor cell 
intravasation (Gruss and Herlyn 2001, Hsu et al 1996). This dynamic change in cadherin 
expression is called the cadherin switch (Miller and Mihm 2006).
1.9 Connexins in cancer
Studies examining the role of gap junctions in cancer have found connexins to be 
able to act as both a tumor promoter and suppressor depending on the stage and type of 
cancer (Naus 2002, Naus and Laird 2010). In knockout Cx32 mouse models, the 
development o f spontaneous tumors was more frequent and these mice were more 
susceptible to chemical induced liver tumors, suggesting Cx32 plays a protective role 
against cancer (Temme et al 1997). Similarly, overexpression of Cx43 in rat 
hepatocarcinomas has been reported to decrease cell proliferation (Ionta et al 2009). 
Conversely, in patients with lung carcinomas, elevated Cx26 expression was associated 
with increased aggressiveness of the tumors (Ito et al 2006). In breast tumor cells, both 
Cx26 and Cx43 have been reported to act as tumor suppressors as evidenced by the 
reduced ability of connexin expressing cells to form colonies in soft-agar (McLachlan et 
al 2006). Furthermore, increased Cx26 expression was also able to slow the proliferation
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of breast tumor cells via gap junction- dependent and independent mechanisms (Kalra et 
al 2006).
1.10 Connexins in human melanoma
At present, very few studies have examined and assessed the role of connexins in 
human melanomas. A consensus as to which connexins are expressed in human 
melanomas has yet to be reached. From melanoma biopsies, the expression of Cx26 in 
these studies was not rigorously classified by stage of disease and Cx26 staining was 
inconsistently detected (de Zwaan and Haass 2010, Ito et al 2000, Saito-Katsuragi et al 
2007). Interestingly, some melanomas had detectable Cx26 expression restricted to the 
tumor edge where cells contact the kératinocytes or the dermis (Haass et al 2010, Ito et al 
2000). To add to this complexity, other studies have reported no expression of Cx26 in 
melanoma biopsies (Braeuer et al 2011, Haass et al 2004, Ito et al 2000, Villares et al
2009) . Likewise, studies characterizing Cx43 expression in melanoma biopsies have not 
been consistent with some biopsies exhibiting the presence of Cx43 (Hsu et al 2000, 
Villares et al 2009), while others found no Cx43 expression (Haass et al 2006, Haass et al
2010) . It is possible that Cx26 and Cx43 expression may change during melanoma 
progression, which could explain why only some melanomas had detectable connexin 
expression while others do not. However, this notion has yet to be tested. In our study, 
three isogenic melanoma cell lines representing different stages of disease progression 
were assessed for connexin expression.
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1.11 Connexins in mouse melanoma
In mouse melanoma studies the most common cell lines used for connexin 
analysis were derived from the B16 parental melanoma line (Daniel-Wojcik et al 2008,
Ito et al 2000, Miura et al 2007, Ohba et al 2007). These B16 melanoma cells can be 
further separated into isogenic sub-lines, commonly referred to as F0, F10 and BL6 cells, 
based on their differences in in vivo aggressiveness (Nakamura et al 2002). Cx43 
expression has been reported in the B16 parental melanoma cells (Daniel-Wojcik et al 
2008); however, Cx43 was not detectable in F10 and BL6 cells (Ito et al 2000). Cx26 
expression on the other hand was detected in F I0 and BL6 cells (Ito et al 2000, Ito et al 
2004, Miura et al 2007, Ohba et al 2007). Furthermore, one in vivo study showed that less 
melanomas metastasized to mouse lungs when Cx26 function was impaired in BL6 cells 
through expression of a dominant-negative Cx26 mutant (Ito et al 2000). Connexin 
expression has yet to be assessed in mouse melanoma tumors formed in the epidermis. In 
our study, Cx26 and Cx43 was characterized in three isogenic melanoma cell lines, F0, 
F10 and BL6 cells and assessed in melanoma microtumors formed in a 3D organotypic 
epidermis.
1.12 Connexins expressed in the epidermis
Gap junction channels are essential for kératinocytes as they play a role in 
development, proliferation and differentiation of the epidermis (Kretz et al 2004,
Langlois et al 2007, Richard 2005, Risek et al 1992). In the human epidermis, Cx26, 
Cx30, Cx31, Cx32, Cx40, Cx43 and Cx45 have all been shown to be expressed (Di et al 
2001, Richard 2000, Salomon et al 1994); likewise Cx26, Cx31, Cx31.1, Cx37 and Cx43
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are expressed in the rodent epidermis (Goliger and Paul 1994, Richard 2000, Risek et al 
1992). In human melanocytes, expression of Cx26 and Cx43 (Hsu et al 2000, Masuda et 
al 2001) have been reported, however, no studies have characterized connexin expression 
in rodent melanocytes. Interestingly, expression of connexins in the epidermis changes 
as kératinocytes differentiate into the stratified layers (Richard 2000, Salomon et al 
1994). For instance in the epidermis of mice, Cx31, Cx37, Cx40 and Cx43 are all 
expressed in the basal layer (Mese et al 2007). The spinosum layer expresses Cx26, 
Cx30.3, Cx31, Cx31.1, Cx37 and Cx43, and the granulosum has Cx26, Cx30, Cx30.3, 
Cx31 and Cx37 (Kretz et al 2004, Mese et al 2007, Richard 2000). The cornified layer 
does not have any connexin expression. Since Cx26 and Cx43 are expressed in both the 
rodent epidermis and in mouse melanomas, it is important to examine the potential gap 
junction channel interaction between melanomas and kératinocyte. Our study addresses 
the spatial distribution and potential role of Cx26 and Cx43 by co-culturing kératinocytes 
and melanomas in both 2D monolayers and in 3D organotypic epidermis.
1.13 Organotypic epidermis
In previous studies, co-culture systems for assessing melanomas have been done 
mainly in a 2D monolayer, such as melanoma interactions with kératinocytes, fibroblasts 
(Hsu et al 2000), and astrocytes (Lin et al 2010). These studies do not however mimic the 
melanoma microenvironment, thus, we propose that it would be more appropriate to grow 
melanomas in a 3D organotypic epidermis. Previous studies have demonstrated that 
human melanomas can successfully form microtumors within human organotypic 
epidermis and xenografts (Meier et al 2000, Santiago-Walker et al 2009, Satyamoorthy et 
al 1999). However, these studies were not used to assess the role of connexins. Our study
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is the first to assess connexin expression and localization in a 3D organotypic epidermis 
derived from rat epidermal keratinocytes (REKs) co-cultured with mouse melanomas. 
REKs are immortalized cells that can differentiate into a stratified epidermis when 
exposed to an air-liquid interface (Baden and Kubilus 1983, Langlois et al 2007, Langlois 
et al 2010, Maher et al 2005). Under these conditions, REKs form well-structured layers 
consisting of the stratum basale, stratum spinosum, stratum granulosum and stratum 
comeum. The REK derived organotypic epidermis is thinner compared to human 
epidermis and human organotypic epidermis, but appropriately mimics the thickness of 
the mouse epidermis in situ (Di et al 2001, Kamibayashi et al 1993, Wiszniewski et al 
2000). Furthermore, connexin expression within the organotypic epidermis was found to 
be spatially distinct, for example, Cx26 was predominantly localized to the suprabasal 
layers, while Cx43 was distributed throughout the entire living cell layer (Langlois et al 
2007, Maher et al 2005). In the present study we used organotypic epidermis and 
melanoma co-cultures to investigate the putative roles of connexins in an epidermal 
microenvironment that mimicked living skin.
1.14 Hypothesis and outline
We hypothesized that connexins regulate the tumorigenic properties of 
melanomas and the interactions melanomas have with the keratinocyte 
microenvironment. To address this hypothesis, we characterize Cx26 and Cx43 in three 
cultured isogenic mouse melanoma cell lines; F0, F10 and BL6 cells. In previous in vivo 
studies, F0 cells were considered to be the least metastatic, while F10 cell had increased 
aggressiveness, and BL6 cells were classified as being highly invasive (Nakamura et al 
2002). We investigated if these differential tumorigenic properties reported in vivo were
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also evident in vitro. In addition, connexins were assessed for their involvement in 
melanoma tumorigenic properties including cell proliferation, migration and anchorage- 
independent growth in soft agar. Finally, to study if  connexin interaction and cross-talk 
existed between keratinocytes and melanomas, cell co-cultures were established and 
examined in 2D and 3D conditions. In these studies, we optimized an in situ 3D 
organotypic epidermal co-culturing model to assess connexin expression and localization 
in a tissue-like microenvironment.
1.15 Objectives
1. Examine the tumorigenic properties of isogenic melanoma cell lines
2. Characterize the presence and role of connexins in melanocytes and melanoma 
tumorigenesis
3. Characterize connexins in the microenvironment of melanoma cells co-cultured 
with keratinocytes
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Role and regulation of Cx26 and Cx43 in Melanoma
2.1 Introduction
Intercellular communication between contacting cells occurs through gap junction 
channels which allow small molecules of less than 1 kDa to pass between cells (Goldberg 
et al 2004, Kelsell et al 2000). Gap junction channels are assembled from two hexameric 
structures called hemichannels which dock at locations of cell to cell contact 
(Goodenough et al 1996). Hemichannels are comprised of six connexins (Cx) and 
presently, 20 connexin family members have been identified in mice and 21 in humans 
(Laird 2006, Sohl and Willecke 2003, Sohl and Willecke 2004). Gap junction channels 
play a vital role in regulating cell differentiation and proliferation (Birkenhager et al 
2010, Lucke et al 1999, Richard 2000). For example, patients with mutant Cx26 
expression have abnormal keratinocyte differentiation resulting in thickening of the 
stratum comeum in the epidermis (Birkenhager et al 2010). While connexins have been 
known to help maintain normal cellular function, connexins have also been attributed to 
cancer tumorigenesis (Naus and Laird 2010). Melanoma is one of the most aggressive 
forms of cancer with a high mortality rate due to its rapid transition from benign to 
metastatic (Jemal et al 2010, Lugassy and Barnhill 2007). Melanomas are derived from 
melanocytes located in the basal layer of the epidermis (Yamaguchi and Hearing 2009). 
Each melanocytes is surrounded by basal keratinocytes and has the unique ability to 
protect the epidermis from UV radiation by producing the pigment melanin (Park et al 
2009). Melanin is able to absorb UV radiation and convert the energy into heat, thus
2 9
minimizing DNA damage in epidermal cells (Yamaguchi and Hearing 2009). However, 
melanocytes with irreversible UV-induced damage can transform into melanomas.
In examining the relationship between connexins and melanomas, the presence of 
Cx26 in human melanomas has been reported (Haass et al 2010, Ito et al 2000, Saito- 
Katsuragi et al 2007), while other studies have found no Cx26 expression (Haass et al 
2004, Haass et al 2006, Ito et al 2000). Likewise, conflicting reports exist as to whether 
Cx43 is expressed in human melanomas biopsied from the skin (Braeuer et al 2011,
Haass et al 2004, Ito et al 2000, Villares et al 2009). Interestingly, Cx26 and Cx43 have 
been identified in human melanocytes (Hsu et al 2000, Masuda et al 2001). As 
melanomas become more aggressive the connexin expression level may change which 
could explain why only some melanomas have detectable levels of Cx26 and Cx43. The 
present study assesses this concept by characterizing connexin expression in three 
isogenic melanoma cell lines that mimic variable levels of tumor progression. In 
melanomas derived from the B 16 mouse line, both Cx43 and Cx26 expression have been 
detected (Daniel-Wojcik et al 2008, Ito et al 2000, Ito et al 2004, Miura et al 2007, Ohba 
et al 2007). Additionally, studies have shown that subcutaneous injections of melanoma 
cells with reduced Cx26 function results in fewer tumor metastasis of the lungs in mice 
(Ito et al 2000, Ito et al 2004, Miura et al 2007, Ohba et al 2007), suggesting that Cx26 in 
melanomas may promote metastasis. However, further studies regarding whether 
connexins promote or inhibit melanoma progression is needed. In rat kératinocytes, the 
expression o f Cx26, Cx31, Cx31.1, Cx37 and Cx43 have been reported (Goliger and Paul 
1994, Richard 2000, Risek et al 1992). Similarly, in human kératinocytes, expression of 
Cx26, Cx30, Cx31, Cx32, Cx40, Cx43 and Cx45 have all been reported (Di et al 2001,
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Richard 2000, Salomon et al 1994). The expression of both Cx26 and Cx43 in rodent 
melanomas and keratinocytes suggests a possible interaction between these cell types 
through the formation of heterocellular gap junctions. Our study addressed this idea by 
co-culturing melanomas with keratinocytes in 2D monolayer and within 3D organotypic 
epidermis.
In the current study, we hypothesized that connexins regulate the tumorigenic 
properties of melanomas and serve to provide direct interactions with the keratinocyte 
microenvironment. Cx26 and Cx43 expression were characterized in three mouse 
isogenic melanoma cell lines of varying aggressiveness. The use of isogenic lines was 
important to normalized the genetic platform and allow us to determine the role of 
connexins during tumor progression. Furthermore, the roles of connexins were evaluated 
for changes in melanoma properties such as cell proliferation, migration and anchorage- 
independent growth in soft agar. In addition, Cx26 and Cx43 were characterized in 
melanomas co-cultured with keratinocytes in a 2D monolayer and grown in a 3D 
organotypic epidermis (Baden and Kubilus 1983, Langlois et al 2010, Maher et al 2005, 
Thomas et al 2007). The in situ co-cultured 3D organotypic epidermis allowed for the 




Mouse melanocytes (CRL-2770) were derived from the B10.BR mouse cell line 
purchased from American Type Culture Collection (ATCC, Manassas, VA). The
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melanocytes were cultured in Ham’s F10 medium (Invitrogen, Carlsbad, CA) 
supplemented with 50 ng/ml phorbol 12-myristate 13- acetate (TPA) with 7% horse 
serum, 100 pg/ml penicillin (Invitrogen, Carlsbad, CA), and 100 pg/ml streptomycin 
(Invitrogen).
Rat epidermal keratinocytes (REKs) are a spontaneously immortalized cell line 
originally described by Baden and Kubilus (Baden and Kubilus 1983). Cells were grown 
in Dulbecco’s Modified Eagle Medium with 4.5 g/L glucose IX (DMEM) supplemented 
with 2 mM L-glutamate, 10% fetal bovine serum (FBS), 100 U/ml penicillin, and 100 
ug/ml streptomycin; all purchased from Invitrogen.
Three B16 melanomas isogenic sub-cell lines derived from the C57BL/6J mouse 
background; F0, F10 and BL6 cells were obtained from American Type Culture 
Collection (ATCC, Manassas, VA). All melanoma cell lines were cultured in Minimal 
Essential Medium (MEM) containing 2 mM L-glutamate, 10% FBS, 100 U/ml penicillin, 
100 pg/ml streptomycin, 0.1 mM MEM non-essential amino acid, MEM Vitamin 
solution and 1 mM MEM sodium pyruvate; all purchased from Invitrogen (Carlsbad, 
CA). All cells were incubated at 37°C at 5.0% CO2.
2.2.2 Generation of Cx26-GFP and Cx43-GFP overexpressing, and shRNA Cx26
knockdown stable cell lines
Stable cell lines for the overexpression of Cx26-GFP, Cx43-GFP and GFP were 
generated in BL6 melanoma cells. The green fluorescent protein (GFP) tag was fused to 
the carboxyl-terminal of wild-type Cx26 and Cx43. BL6 cells were also engineered to 
express a shRNA scrambled control vector and shRNA Cx26 (sh-Cx26) to knockdown
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Cx26 expression. These vectors were constitutively expressed using a cytomegalovirus 
(CMV) promoter. Overexpressing Cx26-GFP and GFP constructs was generated on an 
AP2 replication-defective retroviral vector. Cx26 knockdown construct (sh-Cx26) was 
generated and cloned into the pHl.l-QCXIH retroviral vector as described in Thomas et 
al. (Thomas et al 2007). The Cx43-GFP construct was described in Roscoe et al. (Roscoe 
et al 2005). Three serial retroviral infections were performed as described by Mao et al. 
(Mao et al 2000, Shao et al 2005, Thomas et al 2003). After 3-4 cell passages, the 
infection efficiency was determined by immunofluorescence or Western blot. For sh- 
Cx26 and shRNA scrambled control expressing BL6 cells, 50 pm/ml Hygromycin B 
(Invitrogen) was used to select for cells that were successfully infected with the vector.
2.2.3 Organotypic epidermis co-cultured with melanoma
REKs were plated at 1.5x10s cells/mL on collagen type 1 (BD Science) coated 24 
mm transwell filter inserts with 3 pm high density pores (BD Science), and allowed to 
grow to confluence with growth medium on top and bottom of the well inserts as describe 
by Langlois et al. (Langlois et al 2010). Once confluence was reached, the top medium 
was removed and cells were allowed to interact with the air, creating an air-liquid 
interface for the cells to differentiate. After 14 days, keratinocytes were able to stratify 
into the different epidermal layers. For co-cultures, melanoma cells were plated at 5xl04 
cells/ml on a confluent monolayer of REKs and allowed to grow for one day in the 
presence o f melanoma media. Once the media was removed keratinocytes differentiated 
and the melanoma cells developed microtumors within the epidermal layer. The 
organotypic epidermis was given at least 14 days to grow. At least five biological 
replicates were done per cell line.
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2.2.4 Western blot
Cells were grown to confluence and collected in lysis buffer (150 mM NaCl, 10 
mM Tris-HCl at pH 7.4, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 1 mM sodium 
vanadate, 1 mM sodium fluoride, protease inhibitors from Roche) before sonication. 
Protein concentrations were determined using a bicinchoninic acid protein assay (BCA) 
kit (Pierce, Rockford, 1L) and 60 pg was loaded into each well prior to protein separation 
via 12% SDS-PAGE and then transferred onto nitrocellulose membranes.
Affinity purified rabbit anti-Cx43 antibody (0.1 pg/ml; Sigma, Oakville, ON) and 
rabbit anti-Cx26 antibody (0.2 pg/ml; Invitrogen) were used to probe the Western blot. 
To determine if protein loading was equal, the Western blot was also probed with mouse 
anti-gIyceraIdehyde-3-phosphate dehydrogenase (GAPDH; 0.05 pg/ml; Millipore, 
Billerica, MA). Secondary antibodies for Alexa conjugated anti-rabbit (Invitrogen) and 
anti-mouse (Invitrogen) were used at a 1:10000 dilution. At least three biological 
replicates per cell line were quantified using an infrared fluorescent scanner by Li-Cor 
Odyssey.
2.2.5 Immunocytochemistry of cultured cells
REKs and B16 melanoma cell lines cultured on glass coverslips were fixed with 
10% neutral buffered formalin at room temperature for 30 minutes. Melanocytes were 
cultured on glass coverslips coated with collagen type I and fixed with 10% neutral 
buffered formalin. Cells were then blocked using 3% BSA in phosphate buffered saline 
(PBS) containing 0.1% Triton X-100 for 1 hour at room temperature. Afterwards, cells 
were labeled with rabbit anti-Cx26 (1.0 pg/ml; Invitrogen), rabbit anti-Cx43 (1.0 pg/ml;
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Sigma), and mouse anti- cis- Golgi marker GM130 or GPP130 antibodies (2.0 pg/ml;
BD, Franklin Lakes, NJ) for one hour at room temperature. After repeated washing in 
PBS, cells were stained with anti-rabbit AlexaFluor 555 or AlexaFluor 488 antibodies 
(4.0 pg/ml; Invitrogen) for 1 hour at room temperature. Nuclei were stained with Hoechst 
33342 at (0.1 pg/ml; Molecular Probes, Eugene, OR). Coverslips were mounted and 
imaged on an inverted confocal microscope (Zeiss LSM 510) using a 63X lens.
2.2.6 Organotypic epidermis preparation and immunohistochemistry
Organotypic epidermis was cut into 1 cm2 samples and fixed in 10% neutral 
buffered formalin overnight at 4 °C. Samples were then dehydrated in ethanol and xylene 
before embedding in paraffin wax. Paraffin sections were cut perpendicular to 
organotypic epidermis surface at a thickness of 5 pm and deparaffinized with xylene and 
ethanol solutions to rehydrate the samples followed by heated antigen retrieval using 2 
mM citric acid solution. Sections were blocked using 3% BSA dissolved in PBS and 
0.1% Triton X-100 for 1 hour at room temperature. Sections were then labeled with 
rabbit anti-Cx26 (2.0 pg/ml; Invitrogen), rabbit anti-Cx43 (1.0 pg/ml; Sigma), and mouse 
anti-Melan-A antibodies at (1.0 pg/ml; Abeam Inc. Cambridge, MA). Followed by 
repeated washing in PBS, cells were stained with anti-rabbit AlexaFluor 555 or 
AlexaFluor 488 antibodies (4.0 pg/ml; Invitrogen) for 1 hour at room temperature and 
with Hoechst 33342 for 5 minutes (0.1 pg/ml; Molecular Probes). Sections were mounted 
and images were captured on an inverted confocal microscope (Zeiss LSM 510) using a
63X lens.
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2.2.7 Organotypic quantification and histology
To measure the frequency of microtumors formed by melanoma stable cell lines 
in organotypic co-cultures, random images from five distinct regions of the well insert 
were captured using a 5X lens (2.6 mm ) mounted on an inverted microscope (Leica DM 
IRE2) attached to a charged coupled digital color camera (CCD, Hamamatsu Photonics, 
Japan). Bright field images were collected and the number of microtumors was counted. 
Microtumors were identified as areas of densely packed cells on multiple optical focal 
planes that appeared like tumor nodules in the organotypic epidermis. Microtumors larger 
than 200 pm in diameter were counted per mm and the results were analyzed by a one­
way ANOVA with Tukey’s Multiple Comparison Test. At least four biological replicates 
were used per organotypic co-culture cell line.
For Hematoxylin and Eosin (H&E) staining, the organotypic epidermis was 
sectioned, de-paraffinized and then rehydrated using xylene and gradients of 100%, 95%, 
and 70% ethanol for 6 minutes each. Slides were then placed in 0.4% Hematoxylin 
(Fisher) solution for one minute, followed by acid ethanol to de-stain (1 ml concentrated 
HC1 diluted in 400 ml of 70% ethanol). Washed sections were further stained with 0.5% 
Eosin (Fisher) for another minute and washed further in an ethanol and xylene solution as 
previously described (Langlois et al 2010). Microtumors in the organotypic sections were 
sized by measuring the thickness between where the tumor bordered the upper comified 
and lower basal layers. Microtumor cross-sectional area was measured by tracing the 
edge of the microtumors as denoted by the visible pigmentation or sponge-like structure. 
A second individual who was blinded to the treatments used ImageJ software to measure 
tumor thickness and the area of microtumor formation. At least five organotypic
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replicates were used per co-culture condition with a minimum of 25 images taken per co­
cultured cell line. All images were captured on an inverted microscope (Leica DM IRE2) 
equipped with a 0.63X C-mount adaptor and Micropublisher 5.0 RTV CCD color camera 
(Hamamatsu Photonics, Japan). ProgRes Image Capturing Software was used to render 
color images.
2.2.8 Melanin extraction
Using a protocol modified from Zhao et al.(Zhao et al 2001), melanoma cells 
were first allowed to grow for 72 hrs without changing the media in 60 mm dishes. 
Afterwards, cells were trypsinized using 0.25% trypsin-EDTA and lxlO6 cells were 
collected and centrifuged for 10 minutes at 9000 RPM to collect the pellet. The control 
used was 0.25% trypsin-EDTA solution without cells present. The pelleted cells were 
then dissolved in 1 M NaOH containing 10% dimethyl sulfoxide (DMSO; Sigma) and 
incubated for 2 hours at 70°C to allow the pellet to dissolve. The solution was then 
transferred into cuvettes and measured at an absorbance of 450 nm. At least three 
biological replicates were used per cell condition.
2.2.9 Anchorage-independent growth in soft agar
1.2 % Agarose powder was dissolved in autoclaved double distilled water using a 
hot plate. A ratio of 1:1 and 1:3 of reheated 1.2% agarose solution mixed with growth 
medium made 0.6% and 0.3% agarose solution, respectively, ready for cell culture use. 2 
ml of 0.6% heated agarose solution was transferred onto 6-well plates and allowed to 
cool down to from the agarose gel. 5000 cultured cells were suspended within 0.3% 
agarose solution at a temperature no more than 37°C and layered on top of a 0.6%
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agarose gel and incubated for ten days. Colonies with 10 cells or greater were counted per 
mm2. A minimum of 4 biological replicates were used. Ten random images were 
collected with a 5X lens (2.6 mm2) using an inverted microscope (Leica DM IRE2) 
attached to a CCD color camera (Hamamatsu Photonics, Japan) using OpenLab software.
2.2.10 Migration assay
Cultured cells were first plated on a grid Petri dish and grown to at least 80% 
confluence as a monolayer. Cells were scraped by a rubber scraper from one side of the 
grid line, while the other side of the grid line remained intact. The growth medium was 
replaced with serum reduced Opti-MEM, to minimize cell proliferation. Images were 
taken along the grid line with a 5X lens (2.6 mm ) using an inverted microscope (Leica 
DM IRE2) attached to a CCD color camera (Hamamatsu Photonics, Japan). Images were 
captured along the scrape line at the time the scrape was performed and again after 24 
hours. The distance the cells migrated from one side of the grid line to the other side was 
measured, five times per plate. At least five biological replicates were used per treatment.
2.2.11 Cell proliferation
Cultured cell were plated into individual 6-well plates at 1 x 104 cells/mL. On 
days 1, 2, 4 and 6 cells were dissociated with 500pL of 0.25% trypsin-EDTA (Invitrogen) 
and counted using the Countess Automated Cell Counter (Invitrogen). Statistical analysis 
of four biological replicates included standard error calculations and non-linear 
regression comparison test.
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2.2.12 Preloading dye transfer assay
Cells were grown to 80% confluency in 60 mm culture plates containing one 
coverslip. The cells on the coverslips were removed from the culture plates and preloaded 
with calcein-AM (a membrane- permeable molecule that gives rise to the membrane- 
impermeable green fluorescent dye calcein-AM once inside the cell) and 1,1-  
dioctadecyl-3,3,3 3 -tetramethylindocarbocyanine perchlorate (Dil, a lipophilic 
fluorescent dye that stains membranes red) as described by Goldberg et al. (Goldberg et 
al 1995). Calcein-AM is cleaved upon entering the cell, trapping calcein which then 
fluoresces green. The donor cells containing both dyes were trypsinized and seeded back 
onto cells cultured in 60 mm culture plates from which the coverslips previously came 
from. After four hours of incubation, the percent of donor cells that successfully 
transferred dye to receiving cells were recorded. At least four repeats were done for each 
experimental condition.
2.2.13 Microinjection dye transfer assay
Cell lines were assessed for gap junctional coupling by a dye microinjection 
assay. Cells were plated in 60 mm culture plates and grown to greater than 80% 
confluence. Cells that expressed exogenous GFP, Cx26-GFP or Cx43-GFP were injected 
with 2.5% Lucifer yellow dye (Invitrogen) using an Eppendorf Femtojet with an 
automated pressure microinjector. The cells were monitored for 3 minutes for dye 
transfer between apposing cells as described by Abbaci et al. (Abbaci et al 2008). The 
percentage of microinjected cells that exhibited successful dye transfer to one or more 
cells was recorded. A minimum of 45 injections were done per cell line. Images were
captured on an inverted epifluorescent microscope (Leica DM IRE2) with charged 
coupled camera (Hamamatsu Photonics, Japan) using OpenLab software (PerkinElmer, 
USA).
2.2.14 Statistics
All results shown are presented as mean with standard deviation. From the 
Western blot quantification, BL6 cells expressing Cx26-GFP and sh-Cx26 were 
compared to their related control groups using an unpaired t-test. For the quantification of 
all in vitro studies and organotypic studies, BL6 cells expressing GFP, Cx26-GFP and 
Cx43-GFP were compared using a one-way ANOVA with a Tukey’s Multiple 
Comparison Test. Comparisons between BL6 scrambled control and sh-Cx26 cells were 
made using an unpaired t-test. All tests were calculated and graphed using GraphPad 
Prism 4.03 software (GraphPad Software Inc., USA).
2.3 RESULTS
2.3.1 Melanoma cell lines exhibited similar tumorigenic properties in  v itro
In this study, we used three isogenic melanomas, F0, F10 and BL6 derived from the C57 
B16 mouse line (Nakamura et al 2002). In vivo experiments previously showed that F0 
cells to be the least metastatic compared to F10 and BL6 cells (Itoh et al 2005, Nakamura 
et al 2002, Poste et al 1980). BL6 cells which were derived from F10 cells are considered 
the most invasive, since they can invade through smooth muscle tissue (Nakamura et al 
2002). As a non-tumorigenic control, melanocytes from the B10.BR mouse were used in 
the current study (Govindarajan et al 2003). To determine if the in vitro assays would
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recapitulate the differences in melanoma aggressiveness seen in vivo (Nakamura et al 
2002) all four cell lines were assessed for cell proliferation, anchorage-independent 
growth and migration (Figure 2.1). The proliferation of melanoma cells F0, F10 and BL6 
and control melanocytes were assessed over a 6 day period (Figure 2.1A). The 
tumorigenic melanoma cell lines all demonstrated significantly increased proliferation 
when compared to non-tumorigenic melanocytes (p<0.05), but there were no significant 
differences among the F0, F10 and BL6 cell lines. As expected, melanocytes were not 
able to form colonies within soft agar gel, and thus do not possess the ability for 
anchorage-independent growth (Figure 2.1B). In comparison, melanoma cells F0, F10 
and BL6 were all able to form tumor colonies and demonstrate anchorage-independent 
growth (p<0.05); however, no differences in anchorage-independent growth were found 
among melanoma cell lines. Lastly, the migration ability of melanoma cell lines and 
melanocytes was studied using a scrape assay (Figure 2.1C). Cells were monitored for 
the distance migrated over a 24 hour period in serum-reduced media. All three melanoma 
cell lines F0, F10 and BL6, migrated significantly faster than melanocytes (p<0.05). 
Surprisingly, BL6 melanoma cells migrated significantly slower compared to F0 and F10 
cells.
2.3.2 Cx26 was expressed in a subpopulation of melanomas and localized to the 
cell surface
It has been previously reported that some mouse melanomas express Cx26 (Ito et al 
2004); however, Cx26 localization in melanomas of different tumor progression have yet 
to be characterized. All three melanoma cell lines were cultured and assessed for Cx26 
expression by immunostaining with a Cx26 antibody (Figure 2.2A). Cx26 gap
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Figure 2.1 Isogenic melanoma cells have similar properties except BL6 melanoma 
cells migrated significantly slower compared to FO and F10 melanomas.
Melanoma cell lines and melanocytes were assessed for cell proliferation (A), 
anchorage-independent growth (B) and migration (C). Melanocytes proliferated 
significantly slower compared to all three isogenic melanoma cell lines, however 
no differences were found among FO, F10 and BL6 melanomas (N=4). All three 
isogenic melanoma cell lines (N=5) exhibited similar anchorage-independent 
growth while melanocytes form no colonies (N=3). Asterisks denote statistical 
significance (p<0.01). All melanomas were able to migrate significantly faster 
compared to melanocytes (a, N=5, C), but BL6 cells migrated significantly slower 
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junction-like structures co-distributed with N-cadherin were seen in only a subpopulation 
of all melanoma cell lines. Melanocytes did not have any detectable levels of Cx26 
(Figure 2.2B). In order to investigate the role of Cx26 in melanoma cells, we 
overexpressed Cx26-GFP in BL6 cells using retroviral infection of a construct encoding 
Cx26-GFP (Thomas et al 2007). In cell engineered to express Cx26-GFP, Cx26-GFP 
forms gap junction-like structures on the plasma membrane as labeled by N-cadherin 
(Figure 2.2C). A representative Western blot of BL6 cells overexpressing Cx26-GFP 
revealed increased levels of a predominant 50 kDa species representing Cx26-GFP and 
endogenous Cx26 at 21 kDa (Figure 2.2D, E). The total Cx26 in BL6 cells expressing 
Cx26-GFP (Cx26 + Cx26-GFP species) was -50%  higher compared to control GFP 
expressing BL6 cells. In parallel studies, Cx26 expression was reduced in BL6 cells by 
using shRNA targeting Cx26 (sh-Cx26). BL6 cells expressing a shRNA encoding a 
scrambled control revealed prominent Cx26 species at 21 kDa and 37 kDa (Cx26 dimer), 
while shRNA targeting Cx26 (Sh-Cx26) exhibited significantly reduced levels of both 
Cx26 species (Figure 2.2F, G). Densitometry analysis normalized to GAPDH indicated 
that BL6 cells expressing sh-Cx26 had an approximate -90%  knockdown of Cx26 
compared to the scrambled control.
2.3.3 Intracellular Cx43 in melanomas was partially recruited to the cell surface
by the co-expression of E-cadherin
F0, F10 and BL6 cells were found to express Cx43, which was localized to an 
intracellular compartment in close proximity to the cis- Golgi apparatus (Figure 2.3A). 
Melanocytes did not have any detectable levels of Cx43 expressed (data not shown). This 
suggested that Cx43 trafficking was uniquely regulated in melanomas compared to Cx26,
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Figure 2.3 Cx43 was localized to an intracellular compartment in melanomas and 
recruited to the plasma membrane when co-expressed with E-cadherin.
Cx43 (green) was found in a subpopulations of all three isogenic melanoma cell 
lines, but, unexpectedly, was localized in close proximity to the cis- Golgi 
apparatus (GM130, red), as indicated by the arrows (A). Likewise, overexpressed 
Cx43-GFP (green) was localized in close proximity to the cis- Golgi apparatus 
(GPP130, red) as indicated by the arrows (B). When BL6 cells, which do not 
express endogenous E-cadherin, were transfected with E-cadherin (red), Cx43 
(green) was able to form gap junction-like structures (C). Cx43 (green) in BL6 
cells expressing E-cadherin was co-distributed with N-cadherin (red) along the 
sites of cell-cell apposition as indicated by the arrows (D). The exposure 
conditions used to capture the N-cadherin labeling was the same as that used to 
capture the E-cadherin labeling. Cell nuclei were labeled with Hoechst stain 
(blue). Scale bafs, 10 pm.
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since Cx43 gap junctions were not observed. In an attempt to promote the assembly of 
Cx43 into gap junctions, BL6 cells were engineered to stably overexpress Cx43-GFP 
(Figure 2.3B). However, Cx43-GFP failed to assemble Cx43-based gap junctions and 
remained distributed in close proximity to the cis- Golgi apparatus. In a further attempt to 
have BL6 melanoma cells assemble Cx43-based gap junctions, BL6 cells, which do not 
endogenously express E-cadherin, were engineered to co-express E-cadherin (Figure 
2.3C). Results showed that expression of E-cadherin in BL6 melanoma cells promoted 
the assembly of Cx43 into gap junction plaques at the plasma membrane, as denoted by 
N-cadherin (Figure 2.3D). Co-expression of E-cadherin in BL6 cells did not alter the N- 
cadherin localization. This suggests that E-cadherin can facilitate the assembly of Cx43- 
based gap junctions in melanomas.
2.3.4 Melanoma cells are GJIC-deficient and form functional gap junctions upon
the overexpression of Cx26-GFP, but not Cx43-GFP
Since melanomas were able to form Cx26 gap junction-like structures at the cell 
surface, the functional status of these channels was assessed by a preloading dye assay. 
Kératinocytes which express Cx26 and Cx43 gap junctions exhibited a high incidence of 
dye transfer (Figure 2.4A). However, melanocytes and all three melanoma cell lines 
could not pass dye. Furthermore, BL6 cells overexpressing Cx26-GFP or Cx43-GFP 
were compared to control GFP expressing cells and assessed for functional gap junction 
status by using a microinjection dye transfer assay (Figure 2.4B). Only kératinocytes and 
BL6 cells overexpressing Cx26-GFP demonstrated functional gap junction channels with 
a high incidence of dye transfer as compared to control GFP expressing cells.
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Figure 2.4 BL6 cells overexpressing Cx26-GFP were able to form functional gap 
junction channels.
To assess if gap junction channels were functional, donor cells were labeled with 
calcein-AM and Dil prior to plating on acceptor cells and assessed for calcein 
transfer to contacting cells. Melanocytes and all 3 melanoma cell lines (A) do not 
appear to form function gap junction channels, while kératinocytes demonstrate a 
high incidence of dye transfer (N>6). Both kératinocytes and Cx26-GFP 
overexpressing BL6 cells were able to form functional channels (B), while BL6 
cells expressing GFP or Cx43-GFP did not exhibit significant dye transfer as 
assessed in a dye microinjection assay (n>45). Asterisks denote statistical 
significance (p<0.05). Bar graphs represent means ± s.d.
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2.3.5 Knockdown of Cx26 expression in BL6 ceils caused an increase in cell 
migration and a decrease in pigmentation
BL6 cells overexpressing GFP, Cx26-GFP or Cx43-GFP, as well as cells 
engineered to have reduced Cx26 (sh-Cx26) and the shRNA scrambled control were 
assessed for their role in melanoma tumorigenic properties and melanin production. BL6 
cells expressing sh-Cx26 had a significant increase in migration compared to shRNA 
scrambled control expressing cells (Figure 2.5A), both of which had been treated with 
hygromycin B. BL6 cells overexpressing either Cx26-GFP or Cx43-GFP, but not grown 
under hygromycin selection pressure, had no change in cell migration (Figure 2.5B). 
Melanoma cells were also grown for 3 days and assessed for melanin production. 
Interestingly, knockdown of Cx26 in BL6 cells caused -50%  decrease in melanin 
pigmentation compared to scrambled control, while BL6 cells overexpressing Cx26-GFP 
did not change in pigmentation (Figure 2.5C). No changes in anchorage-independent 
growth (Figure 2.5D) or proliferation (Figure 2.5E) was seen in BL6 cells expressing 
Cx26-GFP, Cx43-GFP, or sh-Cx26.
2.3.6 Melanoma cells do not form gap junction channels with kératinocytes 
capable of dye transfer
To assess if melanomas and kératinocytes were able to form functional gap 
junction channels with one another, cells were co-cultured in a monolayer and a 
preloading dye assay was performed. Importantly, kératinocytes cultured in the absence 
of melanomas express both Cx26 and Cx43 and form gap junction plaque-like structures 
at the cell surface (Figure 2.6A). Kératinocytes, which do not express N-cadherin, were
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Figure 2.5 BL6 cells with reduced Cx26 levels demonstrated a significant increase in 
migration and a reduction in pigmentation.
BL6 cells expressing sh-Cx26 had an increase in migration compared to 
scrambled control expressing cells (N>7; A). There were no significant migration 
differences between BL6 cells expressing Cx43-GFP or Cx26-GFP compared to 
GFP expressing cells (N>7; B). BL6 cells expressing sh-Cx26 had significantly 
less melanin compared to scrambled control (N>3; C). No changes in anchorage- 
independent growth was seen amongst BL6 cell lines (N>6; D) and no cell 
proliferation differences were detected (N>5; E). Asterisks denote statistical 
significance (p<0.05). Bar graphs represent means ± s.d.
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Figure 2.6 No gap junction channels capable of dye transfer were formed between 
kératinocytes and BL6 cells overexpressing Cx26-GFP and Cx43-GFP.
Kératinocytes that express both Cx26 (green) and Cx43 (green) were able to form 
gap junctional plaques on the cell surface (A). Kératinocytes co-cultured with 
BL6 cells overexpressing Cx43-GFP do not form Cx43 (green) heterocellular gap 
junctional plaques (B). Kératinocytes which do not express N-cadherin (red), had 
Cx43 localized on the cell surface, while BL6 cells expressing Cx43-GFP and N- 
cadherin localized Cx43 to an intracellular compartment. Scale bars, 20pm. 
Kératinocytes were able to transfer calcein-AM dye to other kératinocytes, as 
denoted by the asterisk; however, BL6 cells expressing GFP, Cx26-GFP or Cx43- 
GFP were incapable of dye transfer with kératinocytes (N>5, p<0.05, C). Bar 




co-cultured with BL6 cells overexpressing Cx43-GFP. Heterocellular gap junctions did 
not form between these two cell types at the cell surface (Figure 2.6B). Cx43 was 
localized to an intracellular compartment in Cx43-GFP expressing BL6 melanoma cells 
even when co-cultured with keratinocytes. This suggests that Cx43 localization in 
keratinocytes and in melanomas does not change in the presence of the other cell type. 
Dye transfer assays revealed no functional gap junction channels formed between 
keratinocytes and BL6 cells expressing GFP, Cx26-GFP or Cx43-GFP (Figure 2.6C).
2.3.7 Melanoma cells are able to form microtumors in 3D organotypic epidermis
An in situ 3D organotypic epidermal co-culture model was developed to mimic the in 
vivo epidermal environment where melanomas reside. H&E staining of rat epidermal 
keratinocytes (REKs) showed differentiation of keratinocytes into stratified epidermal 
layers consisting of basal, spinosum, granulosum and comified layers when grown for 14 
days at an air-liquid interface (Figure 2.7B). When REKs were co-cultured with 
melanomas, pigmented microtumors developed within the organotypic epidermis (Figure 
2.7A). In the organotypic epidermis, Cx26 was distributed in the spinosum and 
granulosum layers (Figure 2.7C), while Cx43 was distributed abundantly within the 
spinosum and granulosum layers and occasionally localized to the basal layer (Figure 
2.7D). When REKs were co-cultured with melanocytes the melanocytes did not 
proliferate, but rather remained as individual cells primarily spread along the basal layer 
(Figure 2.7E). Interestingly, when FO melanoma cells were co-cultured in organotypic 
epidermis, the melanoma cells were able to proliferate, produce pigmentation and form 
microtumors within the epidermal structure (Figure 2.7F). Most often, the melanoma
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Figure 2.7 Melanoma microtumors were able to form within the 3D organotypic 
epidermis.
Melanoma cells were co-cultured with REKs on top of a collagen layer and 
allowed to grow for 14 days and develop into a 3D organotypic epidermis (A). 
H&E images showed that organotypic epidermis consisting of only REKs, the 
keratinocytes stratified into basal, suprabasal and comified layers (B). 
Immunofluorescent microscopy revealed that Cx26 (green) was predominantly 
localized at the stratum spinosum and granulosum (C). The fluorescent signal in 
the comified layer was deemed non-specific. Cx43 (green) was localized to some 
basal cells but mostly appeared as gap junction-like structures in the spinosum 
and granulosum layers (D). Cell nuclei were stained with Hoechst dye (blue). In 
co-cultures, melanocytes were most often distributed within the organotypic 
epidermis along the basal layer as single cells (E). FO cells formed visible 
pigmented microtumors within the epidermis underneath the comified layer (F). 
In addition to forming microtumors within the epidermis, some F10 and BL6 
microtumors were able to penetrate above the comified layer (G, H) The basal 
layer was located above the dotted lines and the comified layer was located above 
the dashed lines. Bars, 30pm.
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microtumors appear encased inside the epidermal layer between intact basal and comified 
layer. However, in F I0 or BL6 melanoma cell co-cultured with kératinocytes the 
microtumors not only displaced the kératinocytes, but in some rare instances appeared to 
grow above the comified layer (Figure 2.7G, H).
2.3.8 BL6 cells with reduced Cx26 were able to form microtumors with reduced 
pigmentation
BL6 cells overexpressing Cx26-GFP, Cx43-GFP or GFP control, as well as BL6 
cells with sh-Cx26 and the shRNA scrambled control cells were all able to form 
microtumors within the organotypic epidermis (Figure 2.8). The microtumors typically 
appeared between the basal kératinocyte and comified layers. Microtumors were 
distinguishable from kératinocytes by exhibiting pigmentation, disorganization and 
spongy-like architecture within the well-organized epidermal layers. While BL6 cells 
expressing Cx26-GFP (Figure 2.8D), Cx43-GFP (Figure 2.8E) and controls (Figure 
2.8A, C) all formed black pigmented microtumors in the organotypic co-cultures, BL6 
cells with sh-Cx26 (Figure 2.8B) produced grey pigmented microtumors.
2.3.9 Down-regulation of Cx26 in BL6 cells reduced the frequency of microtumors 
formed in organotypic epidermis
To evaluate if connexins affect the ability o f microtumors to form and grow in 
organotypic epidermis, BL6 cells overexpressing Cx26-GFP or Cx43-GFP, and BL6 cells 
with sh-Cx26 levels were assessed for the frequency of microtumor formation, the area 
occupied by microtumors and the microtumor thickness. BL6 cells expressing sh-Cx26
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BL6 cells expressing scrambled (A), sh-Cx26 (B), GFP (C), Cx26-GFP (D) and 
Cx43-GFP (E) were all able to form microtumors within the organotypic 
epidermis as assessed by H&E staining. Keratinocytes co-cultured with BL6 cell 
lines all formed microtumors between the basal and comified layers. Pigmented 
microtumor colonies were visible in the organotypic epidermis formed from BL6 
cell lines, but only BL6 cells with sh-Cx26 formed microtumors with less pigment 
(B). Scale bars, 50pm.
Figure 2.8 BL6 cells with decreased levels o f Cx26 develop pigment-reduced
microtumors when grown in organotypic epidermis.
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H&E sections of melanoma organotypic co-cultures were assessed for the 
frequency of microtumor formation, cross-sectional area of the microtumors and 
microtumor thickness. The number of microtumors formed in the organotypic 
epidermis was imaged by bright field microscopy. All melanoma cell lines formed 
microtumors but BL6 cells expressing sh-Cx26 had fewer microtumors compared 
to those of scrambled control (A). Tumors are outlined by the dashed-lines. Bars, 
100pm. Organotypic co-culture samples were sectioned, H&E stained and 
measured for microtumor area and thickness. Organotypic co-cultures of BL6 
cells expressing Cx26-GFP, Cx43-GFP or sh-Cx26 did not significantly differ in 
microtumor cross-sectional area compared to controls (B) as indicated by the 
dashed-lines. Microtumor thickness also did not differ amongst melanomas cell 
lines compared to controls (C) as shown by the dashed-lines. Asterisk denotes 
statistical significance (p<0.05). Bar graphs represent means ± s.d.
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were examined using a bright field microscope and were found to produce fewer 
microtumors compared to the shRNA scrambled control cells (Figure 2.9A). The cross- 
sectional area and thickness of microtumors were measured on H&E sections, as 
illustrated in BL6 cells expressing sh-Cx26 and scrambled control (Fig 2.9B, C). No 
differences in cross-sectional areas were found among cells engineered to express Cx26- 
GFP, Cx43-GFP or sh-Cx26 compared to control cells (Figure 2.9B). Likewise, the 
thicknesses o f the microtumors from the basal to comified layers were similar when the 
cells were engineered to express Cx26-GFP, Cx43-GFP or sh-Cx26 compared to controls 
(Figure 2.9C).
2.3.10 Melanoma microtumors within the organotypic epidermis do not have
detectable levels of Cx26
The expression profile of Cx26 was evaluated in keratinocyte/melanoma or 
melanocyte organotypic co-cultures where Melan-A was used as a molecular marker for 
cell of melanocytes origin. Cx26 was distributed mostly in the spinosum and granulosum 
kératinocyte layers and did not co-distribute with Melan-A in keratinocyte/melanocytes 
co-culture (Figure 2.10A). BL6 cells expressing scrambled control (Figure 2.10B), sh- 
Cx26 (Figure 2.10C), GFP (Figure 2.10D) or Cx26-GFP (Figure 2.10E) were all 
labeled with Melan-A and formed microtumors between the basal (dotted lines) and 
comified layers (dashed lines). Surprisingly, no detectable Cx26 expression was co­
distributed with Melan-A in any microtumors including microtumors that were 
engineered to overexpress Cx26-GFP. This suggests that endogenous and ectopically 
expressed Cx26 are lost in melanoma microtumors when grown in 3D organotypic
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Figure 2.10 Melanoma microtumors within organotypic epidermis do not have 
detectable Cx26 expression.
Cx26 (green) was localized to the kératinocyte spinosum layer but did not co­
localize with Melan-A (red). Melanocytes (A), scrambled control (B), sh-Cx26 
(C), and GFP (D) expressing BL6 cells all did not express Cx26 in the 3D 
organotypic epidermis. Unexpectedly, BL6 cells engineered to overexpress Cx26- 
GFP (E) also did exhibit any detectable levels of Cx26. Kératinocytes adjacent to 
microtumor cells were rich in Cx26 expression. Cell nuclei are stained with 
Hoechst dye (blue). The basal layer is located above the dotted-lines and the 
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models. However, kératinocytes adjacent to the microtumors all had normal expression 
profiles o f Cx26 in the spinosum and granulosum layers.
2.3.11 Cx43 was not detected in melanoma microtumors formed within the 
organotypic epidermis
Organotypic keratinocytes/melanoma or melanocyte co-cultures were also 
examined for Cx43 expression. Cx43 was predominantly found in the spinosum and 
granulosum layers with a few punctate-like structures in the basal kératinocyte layer. 
However, no cells expressed both Cx43 and Melan-A in keratinocyte/melanocyte co­
cultures (Figure 2.11 A). Kératinocytes adjacent to the microtumors were rich in Cx43 
expression while BL6 cells expressing GFP (Figure 2.1 IB) did not exhibit any detectable 
levels of Cx43 in microtumors. Unexpectedly, BL6 cells overexpressing Cx43-GFP did 
not have detectable Cx43 expression in the microtumors either (Figure 2.11C). This 




Figure 2.11 No detectable Cx43 expression was found in melanoma microtumors 
within 3D organotypic epidermis.
Cx43 (green) was not co-localized with Melan-A (red), suggesting melanocytes 
organotypic epidermis do not express Cx43 (A). BL6 cells expressing GFP (A) 
and Cx43-GFP (C) also had no detectable Cx43 expression within the 
microtumors. Kératinocytes adjacent to microtumors had abundant Cx43 
expression. The basal layer is located above the dotted lines and the comified 
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2.4 Discussion
Gap junction channels allow for intercellular communication to occur between 
contacting cells which helps maintain normal cellular function. It has, however, also been 
shown that gap junctions can also influence tumorigenesis (Naus and Laird 2010). At 
present, the role of connexins in melanoma is poorly understood as some studies have 
detected Cx26 in human melanoma biopsies (Haass et al 2010, Ito et al 2000, Saito- 
Katsuragi et al 2007) while others report no expression of Cx26 in melanomas (Haass et 
al 2004, Haass et al 2006). Likewise, reports of Cx43 expression in human melanomas 
have also been inconclusive (Haass et al 2006, Haass et al 2010, Hsu et al 2000, Villares 
et al 2009). in mouse melanomas, the expression of Cx43 (Daniel-Wojcik et al 2008) and 
Cx26 (Ito et al 2000, Ito et al 2004, Miura et al 2007) has been somewhat more 
consistent. Several studies have reported that Cx26 may even promote melanoma 
metastasis into mouse lungs (Ito et al 2000, Ito et al 2004, Miura et al 2007, Ohba et al 
2007). Nevertheless, a detailed understanding of the role of connexins in melanocyte 
transformation, melanoma tumor progression and the interplay with the surrounding 
epidermis is lacking. We hypothesized that connexins regulate the tumorigenic properties 
of melanomas and their interaction with the kératinocyte microenvironment in the 
epidermis. To study the role of connexin on the interactions between melanomas and 
kératinocytes, a novel heterocellular co-culture assay was used and examined under both 
2D monolayer and 3D organotypic conditions. In brief, our studies revealed that 
melanomas with reduced levels of Cx26 expression formed fewer microtumors within the 
3D organotypic epidermis.
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2.4.1 I n  v itro  melanoma studies do not recapitulate in  v iv o  cell phenotypes
In our study, we assessed the tumorigenic aggressiveness of three isogenic mouse 
melanomas and a non-tumorigenic melanocyte cell line. In vitro assays assessing cell 
proliferation, migration and anchorage-independent growth revealed that all three 
melanoma cell lines possessed tumorigenic properties while melanocytes did not. FO, F10 
and BL6 melanoma cells have been previously reported to demonstrate variable degrees 
of aggressiveness in in vivo studies. For instance, FO cells demonstrated significantly less 
metastases to the lung compared to F10 and BL6 cells following intravenous injections 
(Nakamura et al 2002). It was predicted that clear differences in cell tumorigenicity 
would be evident in classical in vitro studies used to assess tumor progression. 
Unexpectedly, the migration of BL6 cells was significantly slower compared to the FO 
and F10 cells. It is possible that due to the cadherin switch that occurs during the 
transformation of melanocytes to melanomas, N-cadherin expression continues to 
increase as melanomas become more aggressive. Studies have shown that an increase in 
N-cadherin expression can result in an increase in cell-cell contact which could serve to 
reduce cell migration (Takahashi et al 2008, Takeichi 1988).
Surprisingly, there were no differences among FO, F10 and BL6 cells in cell 
proliferation or anchorage-independent growth. In human melanomas, increased 
aggressiveness is associated with higher mitotic rates and deeper skin penetration (Clark 
1991, Haass et al 2010, Schatton and Frank 2008). These unexpected findings emphasize 
the discrepancy between in vitro and in vivo studies and may be due to extrinsic factors 
found normally in the in situ melanoma microenvironment. It has been suggested that 
adhesion molecules like E-cadherin between keratinocytes and melanomas could
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potentially impact tumor progression, as well as growth factors released by fibroblasts in 
the dermis can also regulate melanoma tumorigenesis (Lee and Herlyn 2007, Li et al 
2002). Some studies have also detected the expression of Cx26 and Cx43 in some of the 
B16 melanoma cell lines (Daniel-Wojcik et al 2008, Ito et al 2000, Ito et al 2004, Miura 
et al 2007, Ohba et al 2007) however no encompassing study has yet assessed the 
connexin profile in mouse melanomas of varying aggressiveness.
2.4.2 Differential Cx26 and Cx43 expression and localization in melanomas
Our study examined the expression of Cx26 and Cx43 across all three isogenic 
mouse melanomas cell lines to determine if differences in tumor progression as observed 
in in vivo studies (Nakamura et al 2002) might correlate with the connexin status. 
Interestingly, all 3 melanoma cell lines had similar Cx26 expression in only a relatively 
small subpopulation of cells. This reveals that the melanoma cell lines used in our study 
are heterogeneous with respect to Cx26 expression, which may be expected given that 
tumors are typically heterogeneous in nature. Cx26 in the subpopulation of cells was able 
to assemble into what appeared to be gap junctions at the plasma membrane, but overall 
the isogenic cell lines were poorly coupled similar to melanocytes. When BL6 cells were 
engineered to overexpress Cx26-GFP, Cx26 gap junction plaques became much more 
evident and GJIC increased significantly. After 2 days of 2D co-culturing keratinocytes 
together with BL6 cells overexpressing Cx26-GFP, Cx26 continued to be expressed in 
both cells types but no GJIC was established between these distinct rodent cell lines. This 
suggests that melanoma cells remain GJIC isolated from their keratinocyte 
microenvironment in these 2D cultures. Other studies have proposed that connexins may 
be downregulated in melanomas in order to prevent heterocellular communication with
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resident kératinocytes which could serve to disadvantage the growth of the tumor (Li and 
Herlyn 2000, Schiffner et al 2011, Shih et al 1994). Our studies showed that even if we 
ectopically expressed Cx26 in the melanomas to render them GJIC-competent, they still 
could not establish GJIC with Cx26-positive kératinocytes. Similar to Cx26, Cx43 was 
detected in a subpopulation of melanomas cells but was absent in melanocytes. However, 
unlike Cx26, Cx43 did not assemble into gap junction-like structures but remained in 
close proximity to the c/s-Golgi apparatus. The Cx43 intracellular distribution or the 
GJIC capacity of BL6 cells did not change even when cells were engineered to 
overexpress Cx43-GFP. The overexpression of E-cadherin partially rescued the cell 
surface delivery and assembly of Cx43-gap junctions revealing that melanomas require 
E-cadherin to assemble Cx43 into gap junctions. Furthermore, one study showed human 
melanomas expressing both endogenous Cx43 and E-cadherin was able to form 
functional gap junctions (Bagnato et al 2004). In a wide range of cell types, it has been 
proposed that cadherins is essential for Cx43 hemichannels to dock at the cell surface and 
for gap junction channels to form gap junction plaques (Cotrina et al 2008, Fujimoto et al 
1997, Govindarajan et al 2010). Not surprisingly, in 2D keratinocyte/melanoma cell 
cultures, the melanomas remained GJIC isolated from the Cx43-rich kératinocytes as 
Cx43 overexpressing melanoma cells failed to assemble Cx43-based gap junctions. 
Interestingly, our studies strongly suggest that Cx43 and Cx26 have distinct requirements 
for trafficking to the cell surface and assembly into gap junction plaques in melanoma 
cells. Since Cx43 is a much larger connexin (Sohl and Willecke 2003) and is regulated by 
phosphorylation events (Laird et al 1995, Lampe and Lau 2004) and binding partners 
(Laird 2006, Singh and Lampe 2003), it is possible that melanomas lack or have a defect
in the machinery necessary to assemble Cx43 into gap junctions but has the basic 
mechanisms necessary for Cx26 to form gap junctions. Cx26 can be regulated by binding 
proteins, however, are not able to be regulated by phosphorylation (Laird 2006, Thomas 
et al 2005).
2.4.3 Melanomas with reduced Cx26 expression have increased migration and 
decreased pigmentation
BL6 cells overexpressing Cx26-GFP revealed no changes in proliferation, 
migration or anchorage-independent growth. This indicates that an increase in Cx26 
expression and subsequent increase in GJIC does not influence these tumorigenic 
properties. Equally, no changes were observed in BL6 cells overexpressing Cx43-GFP, 
which was to be expected. Cx43 was localized within an intracellular compartment in 
melanomas, therefore was unable to form functional gap junction channels or interact 
with a binding partner that may have downstream mechanisms affecting tumorigensis 
(Laird 2006). Interestingly, BL6 cells with reduced Cx26 expression produced less 
melanin pigment but were more migratory. It has been speculated that melanin 
production in melanomas is associated with melanoma progression (Lazova and Pawelek 
2009), however, mechanisms by which Cx26 regulates melanin production is unknown. 
Furthermore, another study examining the role of Cx26 in migration found that the 
decreased expression of Cx26 in neuronal cells led to a decrease in cell migration by an 
unknown mechanism (Elias et al 2007). This demonstrates that although Cx26 is 
involved in cell motility its role may differ between cell types. Surprisingly, the increase 
in GJIC in BL6 cells overexpressing Cx26-GFP did not affect the melanoma pigment 
production or migratory property. Therefore, the phenotypic changes in BL6 cells with
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reduced Cx26 expression are likely the result of GJIC-independent mechanisms (Naus 
and Laird 2010), perhaps through binding partners or may involve connexins mimicking 
adhesion molecules. A recent study has demonstrated that gap junction channels can 
behave similarly to adhesion molecules and that may affects cell motility (Elias et al 
2007). At present, E3-ubiquitin ligase (OCP1) has been identified to be a binding partner 
of Cx26 (Henzl et al 2004, Laird 2010), as well as caveolin-1 (Schubert et al 2002). 
However, the specific mechanisms of how Cx26 binding partners may change these 
cellular properties are still unknown and quite possibly that the binding partners involved 
have yet to be identified.
2.4.4 Melanomas with reduced Cx26 formed fewer microtumors in organotypic 
epidermis
To better mimic the in vivo melanoma microenvironment, mouse melanoma cells 
were co-cultured with REKs in a 3D organotypic epidermis. This novel method of 
studying mouse melanomas utilizes organotypic epidermis derived from REKs which 
have been previously characterized and shown to share similar structural properties and 
connexin expression profiles as mouse epidermis (Baden and Kubilus 1983, Kamibayashi 
et al 1993, Langlois et al 2007, Maher et al 2005). In organotypic 
keratinocyte/melanocyte co-cultures, melanocytes were typically localized along the 
basement membrane, remaining as pigmented single cells closely similar to their 
distribution in human epidermis (Hsu et al 2002, Schatton and Frank 2008). In 
keratinocyte/melanoma organotypic co-cultures, all 3 melanoma cell lines developed 
microtumors between the basement membrane and the comified layer. The ability for 
mouse melanocytes and melanomas to grow in the 3D organotypic model with REKs
had not been previously reported. In addition to melanomas successfully growing in the 
organotypic epidermis, the microtumors were also characterized as being pigmented, 
with disorganized cell nodules often displaced the keratinocyte epidermal layers 
reminiscent of in situ human melanomas (Santiago-Walker et al 2009). In some rare 
instances, the microtumors proliferated above the comified layers, clinically known as 
ulceration, which is associated with highly aggressive melanomas (Schatton and Frank 
2008). Taken together, these findings enabled us to conclude that the organotypic 
keratinocyte/melanoma co-cultures recapitulated melanomas in situ.
Melanoma cells with altered connexin expression were also co-cultured in the 3D 
organotypic epidermis and assessed for frequency of tumor formation and tumor size, as 
indicators o f melanoma aggressiveness (Clark 1991, Schatton and Frank 2008). 
Interestingly, BL6 cells with reduced Cx26 expression formed fewer microtumors in the 
organotypic epidermis but the ones that did form grew to a similar size as controls. This 
suggests that Cx26 likely regulates the initiation of tumor formation but not tumor 
growth. While reduced Cx26 function in melanomas has been previously implicated in 
decreasing the number of secondary metastatic tumors formed in the lungs (Ito et al 
2000), this is the first time a reduction in Cx26 expression had comparable changes in 
tumor incidences in the epidermis. Furthermore, since there was no gap junctional 
coupling between keratinocytes and melanomas in the co-culture dye transfer assay, the 
observed changes in BL6 cells with reduced Cx26 expression are likely due to GJIC- 
independent mechanisms. It is likely that Cx26 may be influencing melanoma 
tumorigenesis through direct or indirect interactions with binding partners, like OCP1 and 
caveolin-1 (Henzl et al 2004, Laird 2010). Caveolin-1 has been previously reported to be
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expressed in both human and mouse melanomas (Arpaia et al 2011, Fecchi et al 2011, 
Schubert et al 2002). However, the mechanisms by which Cx26 may act through these 
binding proteins to affect tumorigenesis is unknown. It is also possible that Cx26 may be 
acting through a binding partner yet to be identified.
In the 2D co-culture studies using kératinocytes and melanomas, BL6 cells were 
engineered to constitutively express Cx26-GFP or Cx43-GFP using a highly active CMV 
promoter. Under these conditions, expression of either GFP-tagged connexins was easily 
detectable. Unexpectedly, the expression of both Cx26 and Cx43 was not detected in 
melanoma microtumors formed within the 3D organotypic epidermis. Cx26 and Cx43 
expression was however observed in the differentiated kératinocytes surrounding the 
microtumors. This suggests that when grown in 3D organotypic co-culture, melanoma 
microtumors demonstrate post-transcriptional regulation like protein degradation that 
decreases the level of these connexins (Laird 2006). In the 2D co-culture system, 
melanomas and kératinocytes were only grown for two days, while in the 3D organotypic 
model, kératinocytes and melanomas were grown for an extended 14-day period. We 
speculate that melanomas have the unique ability of degrading connexins during 
tumorigenesis in the organotypic co-culture. It is possible that in melanomas the 
expression of Cx26 plays a critical role in early microtumor formation and then later 
decreases Cx26 levels, possibly to become communication-deficient and isolated from 
the kératinocyte microenvironment during tumor growth (Li and Herlyn 2000, Schiffner 
et al 2011). Furthermore, increased hypoxia is often associated with tumor formation 
leading to increased hyperacidity and cellular stress, ultimately effecting metabolic and 
degradation rates within tumor cells (Gatenby and Gillies 2004). Potentially, melanoma
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microtumors within the organotypic would acquire addition changes such as epigenetic 
modification and mutations that could further influence the expression of connexins 
(Singal et al 2000). Hence, BL6 cells with reduced Cx26 expression throughout the entire 
time-span of tumor progression had a significant decrease in the number of microtumors 
formed in the epidermis, but not in microtumor size.
In conclusion, the assessment of Cx26 and Cx43 in both 2D and 3D in vitro 
studies has revealed a possible key role for Cx26 in melanoma migration and as a 
potential tumor promoter. Our study demonstrated that Cx26 may in fact regulate 
melanoma tumorigenic properties through GJIC-independent mechanisms. Furthermore, 
our study also revealed that connexins expression may be reduced during tumor 
progression. This suggests that melanoma tumors may decrease the levels of connexin to 
become communication-deficient with their microenvironment, preventing external 
regulatory mechanisms from limiting tumor growth.
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3.1 Conclusion and Summary
O b je c tiv e  1. E x a m in e  th e  tu m o rig en ic  p r o p e r t ie s  o f  iso g e n ic  m e la n o m a  c e l l  lin e s
Prior to our study, all 3 isogenic mouse melanomas cells FO, F10 and BL6, had 
only been assessed for their aggressiveness in forming metastases in  v iv o . FO cells formed 
the least number of metastasized tumors in the lungs while F10 and BL6 cells formed 
significantly more tumors following intravenous injections (Nakamura et al 2002). The 
tumorigenic properties of these 3 melanomas however had not been directly compared in  
v itro . Our study revealed that all 3 melanomas cell lines possessed tumorigenic 
properties, but no significant differences in cell proliferation or anchorage-independent 
growth were observed among these isogenic cell lines. Conversely, in  v iv o  biopsies from 
highly aggressive tumors have demonstrated elevated labeling for proliferative marker, 
Ki67 (Haass et al 2010, Nurmenniemi et al 2009) and showed increased number of 
colonies formed in soft agar (Carney et al 1980, Song et al 2002), however, this was not 
the case for the 3 isogenic melanoma cell lines. Surprisingly the BL6 cells, which are 
reported to be the most aggressive in v ivo , exhibited significantly slower migration in  
v itr o  compared to F0 and F10 cells. This decrease in BL6 cell migration may be 
attributed to an increase in N-cadherin expression in more aggressive tumor cells, which 
has been reported to elevate intercellular connections subsequently decreasing cell 
migration (Takahashi et al 2008, Takeichi 1988). Collectively, these studies suggest that 
the in  v itr o  2D environment does not readily recapitulate the increasing aggressiveness of
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tumorigenic properties exhibited by these isogenic cell lines in  v ivo . It is possible that the 
in  v itro  environment may lack certain growth factors and metabolites that are usually 
found in the in  v iv o  microenvironment necessary for melanomas tumorigenesis.
Therefore, it is important to develop a cell culture model that better mimics the in  s itu  
melanoma microenvironment.
O b je c t iv e  2. C h a r a c te r iz e  th e  p r e s e n c e  a n d  r o le  o f  co n n ex in s  in  m e la n o c y te s  a n d  
m e la n o m a  tu m o r ig en esis
Our study detected Cx26 expression and gap junctions in a small subpopulation of 
all 3 melanoma cell lines. However, similar to melanocytes, the isogenic melanoma cell 
lines remained poorly coupled. This is comparable with other breast tumor cell lines, 
which have been reported to express low levels of Cx26 with no functional GJIC 
(McLachlan et al 2006). When Cx26-GFP was ectopically expressed in BL6 cells, the 
vast majority o f the cells were able to localize Cx26 to the cell surface and form 
functional gap junctions. Similar to Cx26, endogenous Cx43 was expressed in only a 
small subpopulation of melanoma cells; however, Cx43 was localized within an 
intracellular compartment in close proximity to the Golgi apparatus, uniquely seen in 
melanomas. Overexpression of Cx43-GFP in BL6 cells failed to facilitate the assembly of 
Cx43-positive gap junctions unless cells were also engineered to express E-cadherin. This 
revealed that Cx43 not only is regulated differently from Cx26, but also Cx43 requires 
the presence of E-cadherin in melanomas to assemble into gap junctions. Interestingly, 
due to the cadherin switch during tumorigenesis which involves the down-regulated of E- 
cadherin in tumor cells and up-regulation of N-cadherin (Miller and Mihm 2006), it is
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possible that at an earlier time point when melanomas did have some E-cadherin 
expression Cx43 could have localized on the cell surface.
Our study also examined the role of Cx26 and Cx43 in melanoma tumorigenesis 
using in vitro studies for cell proliferation, anchorage-independent growth and migration. 
Although Cx26 and Cx43 do not appear to play a role in melanoma cell proliferation or 
colony formation in soft agar, interestingly, we did observe that in BL6 cells with 
reduced levels of Cx26 resulted in an increase in cell migration and had a decrease in 
pigmentation. Paradoxically, breast cancer cells with overexpression of Cx26 
demonstrated decreased cell migration (McLachlan et al 2007), while neuronal cells with 
reduced Cx26 expression had also a decrease in cell migration (Elias et al 2007). This 
reveals that the role of Cx26 in migration may vary depending on the cell type. However, 
the change in melanoma pigmentation by Cx26 was unexpected as no previous studies 
have reported this finding. While the mechanism by which Cx26 regulates melanin 
production is unknown, it is interesting to note that it has been speculated that melanin 
production in melanomas may be associated with melanoma progression (Lazova and 
Pawelek 2009). Furthermore, BL6 cells overexpressing Cx26-GFP with significant 
increases in gap junctional coupling surprisingly had no observable effect on cell 
migration and pigmentation. This suggests that Cx26 most likely regulates melanoma 
phenotype through a GJIC-independent mechanism. It is possible that Cx26 may be 
acting directly or indirectly with binding partners that may have downstream effects on 
cell motility and pigmentation. Such binding partners include organ of Corti protein 1, a 
subunit of SCF ubiquitin ligase (Henzl et al 2004) and caveolin-1 (Bailey and Liu 2008), 
however, it is possible that a Cx26 binding partner yet to be identified may be involved.
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Potentially, connexins may also contribute and act as an adhesion molecule between 
contacting cells, thus limiting the extent of cell migration as suggested by Elias et al. in 
2007 (Elias et al 2007).
O b je c tiv e  3. C h a r a c te r iz e  co n n ex in s in m e la n o m a s  w ith in  th e m ic ro e n v iro n m e n t o f  
k é r a tin o c y te s
To determine if melanomas and kératinocytes interact with each other through 
gap junction channels both 2D and 3D co-culture models were used. In the 2D co-culture 
model, rat epidermal kératinocytes and mouse melanomas were grown for 2 days and 
assessed for functional gap junction coupling. Although both kératinocytes and BL6 cells 
with ectopic Cx26-GFP expression were able to form homocellular Cx26-based gap 
junctions, no functional heterocellular coupling was detected. As for Cx43 expression in 
the 2D co-culture model, kératinocytes were able to form homocellular gap junctions but 
likewise could not form heterocellular gap junctions with BL6 cells. Intriguingly, the 
cancer-free model, human melanocytes have been reported to express Cx43 and 
functionally couple with neighboring kératinocytes (Hsu et al 2000, Masuda et al 2001) 
suggesting that in s itu  melanocytes may cross-talk with kératinocytes. Kératinocytes have 
also been reported to be able to regulate and maintain the cellular function of 
melanocytes, possibly through structural interactions mediated by E-cadherin (Lee and 
Herlyn 2007, Li et al 2002, Tang et al 1994). However, as melanocytes undergo 
transformation, E-cadherin expression is lost and melanomas localize Cx43 into an 
intracellular compartment as seen in our study. Interestingly, studies have shown that 
human melanoma cells are able to form functional heterocellular gap junctions with 
fibroblasts and that mouse melanomas are able to couple with N-cadherin expressing
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endothelial cells (Hsu et al 2000, Ito et al 2000, Saito-Katsuragi et al 2007). This suggests 
that melanomas may selectively regulate the function of gap junctions with other cell 
types through cadherin-mediated mechanisms. Ultimately, as melanoma tumors grow in 
the epidermis, it becomes increasingly more isolated from the keratinocyte 
microenvironment as tumors progress.
To better replicate the in vivo melanoma epidermal environment, we used an in 
situ 3D organotypic model to assess the tumorigenic properties of melanoma when co­
cultured with keratinocytes. In the keratinocyte/melanocytes organotypic, melanocytes 
were distributed along the basal membrane and grew as single pigmented cells, 
mimicking the human epidermis (Hsu et al 2002, Schatton and Frank 2008). In the 
keratinocyte/melanoma organotypic cultures, all 3 melanoma cell lines were able to form 
pigmented microtumors embedded within the epidermis between the basal membrane and 
the comified layer. In rare cases, microtumors formed by F10 and BL6 cells grow above 
the comified layer of the epidermis, reminiscent of ulceration, which is seen in highly 
aggressive in situ human melanomas (Schatton and Frank 2008). Our study demonstrates 
a new and reliable strategy to investigate mouse melanomas in an organotypic epidermal 
environment that closely resembles in situ human melanomas.
Interestingly, when BL6 cells with reduced Cx26 expression were co-cultured in 
the 3D organotypic epidermis fewer microtumors were formed, but microtumor size did 
not change. To our knowledge, this is the first reported case of Cx26 affecting melanoma 
tumorigenesis in the epidermis. Previously it had been reported that decreased Cx26 
function in melanomas formed fewer secondary tumors in mouse lungs (Ito et al 2000). 
This suggests that Cx26 may in fact be a tumor promoter in melanomas, specifically
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during the initial stages of tumor formation but not tumor growth. Conversely, connexins 
in hepatocarcinomas (Ionta et al 2009, Omori et al 1996) and glioblastomas (Schubert et 
al 2002) have been proposed to be tumor suppressors. Furthermore, increased Cx26 
expression reduced breast tumor growth (Lee et al 2002, McLachlan et al 2006). These 
paradoxical findings may be related to the stage of the tumor progression or be cell type 
specific (Naoi et al 2007). Thus, Cx26 may act as either a tumor suppressor or a 
promoter, depending on the carcinoma. Surprisingly, BL6 cells expressing Cx26-GFP, 
which could not form functional gap junctions with kératinocytes, also did not 
demonstrate altered number of microtumors formed in the organotypic culture. 
Collectively, this further reinforces the suggestion that Cx26 acts through a GJIC- 
independent mechanism involving a binding partner such as caveolin-1. Caveolin-1 has 
been reported to act as both a tumor promoter and suppressor depending on cell type and 
tumor stage (Bailey and Liu 2008, Goetz et al 2008), however, no studies have yet 
examined the relationship between Cx26 and caveolin-1 in melanoma tumorigenesis.
Surprisingly, no Cx26 or Cx43 was detected in the melanoma microtumors even 
when overexpressed. This was unexpected considering a cytomegalovirus promoter was 
used to constitutively drive the expression of Cx26-GFP and Cx43-GFP in BL6 cells. It is 
possible that during the 14 days of organotypic epidermal growth, melanoma cells 
dynamically destabilize and degrade the connexin mRNA or connexin protein. It is also 
likely that as the microtumors continued to grow, further epigenetic and mutational 
changes may have occurred that could affect the downstream production of connexin 
proteins. For example in MCF-7 breast cancer cells, hyperméthylation of the Cx26 
coding region has been reported to cause decreased protein expression (Singal et al
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2000). Solid tumors are also known to be hypoxic which leads to cellular stress and
changes in degradation pathways (Gatenby and Gillies 2004). At present, the mechanism
by which melanomas decrease connexin expression is speculative and require further
studies. Potentially, Cx26 and Cx43 were expressed during the early stages of melanoma
onset in the epidermis and as tumor progression continued, melanomas became
>
increasingly more GJIC-deficient and disconnected from their microenvironment. This 
once more hints at the idea that the loss of interaction between melanomas and its 
keratinocyte microenvironment may facilitate tumor progression (Li and Herlyn 2000, 
Schiffner et al 2011, Shih et al 1994). Similarly, loss of Cx26 and Cx43 expression has 
also been reported in mammary cells that transform (Hirschi et al 1996, Lee et al 1991). 
Therefore, regulating connexin expression in early stage melanomas may have 
therapeutic value.
3.2 Future Studies
In our study, we determined that Cx26 may promote tumorigenesis in melanomas. 
Reducing the expression of Cx26 in BL6 cells resulted in an increase in cell migration 
and a decrease in the number of microtumors formed in the 3D organotypic epidermis. 
Previous reports have suggested the interaction between melanomas and endothelial cells 
during invasion involves adhesion molecules (Braeuer et al 2011, Villares et al 2009). 
Therefore, it would be important to determine if connexins play a role in cell adhesion 
and invasion. The standard cell adhesion assay involves cell culturing on fibronectin, 
collagen and laminin coated plates. The adhesion assay can further be modified to include 
co-culture models where melanomas are plated on a monolayer of keratinocytes, 
fibroblasts or endothelial cells and assessed (Braeuer et al 2011, Villares et al 2009).
Melanoma cells can also be assessed for invasion by using matrigel, a gel-like protein 
complex that mimics the extracellular environment (Ouyang et al 2006). However, both 
adhesion and invasion assays are considered in vitro and therefore may not truly 
represent the in vivo melanoma microenvironment.
To better mimic the microenvironment and assess for connexin involvement, co­
culturing of melanomas in a in vivo chick embryo chorioallantoic membrane model 
(chick-CAM) can be used to further examine tumor invasive properties like intravasation 
and extravasation (Lugassy and Barnhill 2007, Oppitz et al 2007). The chick-CAM model 
has the advantage of being able to supply nutrition to tumor cells like endogenous 
metabolites, hormones, growth factors and chemokines that are otherwise not available 
under cell culture conditions. Furthermore, tumors with heterogeneous characteristics can 
develop within a multi-cellular environment as it has already been demonstrated to work 
for B16 cells (Oppitz et al 2007). The chick-CAM model may provide new insights 
concerning the role connexins in melanoma invasion, extravasation, intravasation and 
angiogenesis at both the primary and secondary tumor sites.
Another in situ model for assessing mouse melanomas would be expand the 3D 
rodent organotypic epidermis model used in the current study to include a dermal layer, 
similar to human organotypic studies (Meier et al 2000, Nystrom et al 2005, Santiago- 
Walker et al 2009). By intermixing rodent fibroblast cells into the collagen gel to 
simulate the dermis and growing the rodent organotypic epidermis on top it should be 
possible to better recapitulate skin. Potentially, with the inclusion of fibroblasts, 
additional chemokines will be present in the 3D organotypic which may induce 
melanomas to grow and invade from the epidermal layer into the dermal layer. Moreover,
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connexins can be characterized in both 2D and 3D co-cultured fibroblast/melanoma 
models.
Overall, in our study, we developed a novel method for studying mouse 
melanomas by mimicking the in situ epidermal microenvironment using rat epidermal 
kératinocytes. We determined that Cx26 expression seems to play a pivotal role in 
melanoma tumorigenesis and may in fact act as a tumor promoter. However, further 
research is needed to determine the mechanisms by which Cx26 acts to affect melanoma 
tumor progression.
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